1. Home
  2. BEP vs RDY Comparison

BEP vs RDY Comparison

Compare BEP & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Renewable Partners L.P.

BEP

Brookfield Renewable Partners L.P.

N/A

Current Price

$34.18

Market Cap

10.3B

Sector

Utilities

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$13.45

Market Cap

11.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BEP
RDY
Founded
1999
1984
Country
Canada
India
Employees
5870
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
11.6B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
BEP
RDY
Price
$34.18
$13.45
Analyst Decision
Buy
Strong Buy
Analyst Count
10
1
Target Price
$35.70
$16.90
AVG Volume (30 Days)
975.3K
3.1M
Earning Date
05-01-2026
05-12-2026
Dividend Yield
4.71%
0.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.09
$7.72
Revenue Next Year
N/A
$3.50
P/E Ratio
N/A
$18.67
Revenue Growth
N/A
N/A
52 Week Low
$22.64
$12.19
52 Week High
$35.97
$16.17

Technical Indicators

Market Signals
Indicator
BEP
RDY
Relative Strength Index (RSI) 54.00 50.37
Support Level $32.05 $12.90
Resistance Level $34.91 $14.06
Average True Range (ATR) 0.88 0.26
MACD -0.03 0.03
Stochastic Oscillator 71.49 72.51

Price Performance

Historical Comparison
BEP
RDY

About BEP Brookfield Renewable Partners L.P.

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: